Insulet
PODD
$170.87
Share price
-0.62%
Change (1 day)
-46.41%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.85 B
According to Insulet's latest financial reports the company's total liabilities are $1.85 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Insulet - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.85 B | 4.55% |
| 2022-12-31 | $1.77 B | 18.91% |
| 2021-12-31 | $1.49 B | 17.58% |
| 2020-12-31 | $1.26 B | 18.96% |
| 2019-12-31 | $1.06 B | 48.9% |
| 2018-12-31 | $0.71 B | 8.87% |
| 2017-12-31 | $0.65 B | 67.28% |
| 2016-12-31 | $0.39 B | 63.23% |
| 2015-12-31 | $0.24 B | 12.99% |
| 2014-12-31 | $0.21 B | 30.6% |
| 2013-12-31 | $0.16 B | 6.16% |
| 2012-12-31 | $0.15 B | 11.04% |
| 2011-12-31 | $0.13 B | 53.98% |
| 2010-12-31 | $90 M | -24.24% |
| 2009-12-31 | $0.11 B | 48.25% |
| 2008-12-31 | $80.12 M | 108.31% |
| 2007-12-31 | $38.46 M | -75.79% |
| 2006-12-31 | $0.15 B | 91.72% |
| 2005-12-31 | $82.88 M | 15.71% |
| 2004-12-31 | $71.63 M | 101.16% |
| 2003-12-31 | $35.6 M | -1.54% |
| 2002-12-31 | $36.16 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 5,223.85% | 🇺🇸 USA |
 Abbott Laboratories ABT | $34.38 B | 1,753.25% | 🇺🇸 USA |
 Medtronic MDT | $38.84 B | 1,993.24% | 🇮🇪 Ireland |
 Eli Lilly LLY | $53.14 B | 2,764.06% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | $0.63 B | -65.56% | 🇺🇸 USA |
 ICU Medical
ICUI | $2.25 B | 21.53% | 🇺🇸 USA |
 DexCom DXCM | $4.23 B | 128.26% | 🇺🇸 USA |